Register Login

Armata Pharmaceuticals Inc. (ARMP)

(90% Positive) Armata Pharmaceuticals Inc. (ARMP) Announces Enrollment Update for initiate Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Full text
Register to leave comments
  • News bot Jan. 29, 2026, 6:28 p.m.

    📋 Armata Pharmaceuticals Inc. (ARMP) - Clinical Trial Update

    Filing Date: 2026-01-13

    Accepted: 2026-01-13 07:10:46

    Event Type: Clinical Trial Update

    Event Details:

    Armata Pharmaceuticals Inc. (ARMP) Announces Clinical Trial Update Armata Pharmaceuticals Inc. (ARMP) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: initiate, Center
    • Diseases/Conditions: complicated S
    • Clinical Stage: Phase 3 study, Phase 3
    • Collaboration: ARMP

    🔬 Clinical Development Pipeline (Armata Pharmaceuticals Inc.):

    Product Type Development Stage Therapeutic Area Source
    AP-SA02 BIOLOGICAL Phase PHASE1 Bacteremia ClinicalTrials.gov
    Placebo OTHER Phase PHASE2 Non-cystic Fibrosis Bronchiectasis ClinicalTrials.gov
    AP-PA02 BIOLOGICAL Phase PHASE2 Non-cystic Fibrosis Bronchiectasis ClinicalTrials.gov
    Placebo (for Cohort 10^9) BIOLOGICAL Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Placebo (for Cohort 10^8) BIOLOGICAL Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    AB-SA01 (10^9 PFU per phage) BIOLOGICAL Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    AB-SA01 (10^8 PFU per phage) BIOLOGICAL Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    C16G2 Gel DRUG Phase PHASE2 Dental Caries ClinicalTrials.gov
    C16G2 Rinse DRUG Phase PHASE2 Dental Caries ClinicalTrials.gov
    C16G2 DRUG Phase PHASE2 Dental Caries ClinicalTrials.gov
    AB-SA01 BIOLOGICAL Preclinical None ClinicalTrials.gov
    AB-PA01 BIOLOGICAL Preclinical None ClinicalTrials.gov
    Placebo Strip OTHER Phase PHASE2 Dental Caries ClinicalTrials.gov
    C16G2 Strip DRUG Phase PHASE2 Dental Caries ClinicalTrials.gov
    Placebo Varnish DRUG Phase PHASE2 Dental Caries ClinicalTrials.gov
    C16G2 Varnish DRUG Phase PHASE2 Dental Caries ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Armata Pharmaceuticals Inc.
    • Ticker Symbol: ARMP

Search

News categories